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Abstract: The larynx and associated laryngopharyngeal regions are innervated by the superior
laryngeal nerve (SLN) and are highly reflexogenic. Transient receptor potential (TRP) channels have
recently been detected in SLN innervated regions; however, their involvement in the swallowing
reflex has not been fully elucidated. Here, we explore the contribution of two TRP channels, TRPV1
and TRPM8, located in SLN-innervated regions to the swallowing reflex. Immunohistochemistry
identified TRPV1 and TRPM8 on cell bodies of SLN afferents located in the nodose-petrosal-jugular
ganglionic complex. The majority of TRPV1 and TRPM8 immunoreactivity was located on
unmyelinated neurons. Topical application of different concentrations of TRPV1 and TRPM8
agonists modulated SLN activity. Application of the agonists evoked a significantly greater
number of swallowing reflexes compared with the number evoked by distilled water. The interval
between the reflexes evoked by the agonists was shorter than that produced by distilled water.
Prior topical application of respective TRPV1 or TRPM8 antagonists significantly reduced the number
of agonist-evoked reflexes. The findings suggest that the activation of TRPV1 and TRPM8 channels
present in the swallowing-related regions can facilitate the evoking of swallowing reflex. Targeting the
TRP channels could be a potential therapeutic strategy for the management of dysphagia.
Keywords: TRPV1; TRPM8; Superior laryngeal nerve; Swallowing reflex; Dysphagia
1. Introduction
The pharyngeal and laryngeal regions are important areas for swallowing, respiration,
and phonation, and are sources of vital reflexes, such as the swallowing reflex [1–6]. These regions
are innervated by glossopharyngeal (IX) and vagus (X) nerves [6–11]. The pharyngeal region is
supplied by a nerve-plexus, named as the pharyngeal plexus, mainly formed by the pharyngeal
branches of glossopharyngeal (IX-ph) and vagus (X-ph) nerves [6,7]. The larynx and associated
laryngopharyngeal regions are mainly supplied by the superior laryngeal nerve (SLN), a branch
of the vagus (X) nerve [8–12]. Sensory branches of the SLN innervate the anterior wall of the
laryngopharynx, the laryngeal surface of the epiglottis, the aryepiglottic folds, and the larynx as
far as the vocal folds and upper esophagus [2,6,8–12]. The cell bodies of sensory nerves innervating the
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larynx and pharynx in rats are distributed in the nodose-petrosal-jugular ganglionic complex (NPJc),
which consists of nodose (NG), petrosal (PG), and jugular (JG) ganglia [11,12]. The sensory nerves
innervating the pharyngeal and laryngeal regions respond to various chemical stimuli, including
acids and salts [13–17]. However, the mechanism underlying activation of sensory nerves by
chemicals has not been fully elucidated. Transient receptor potential (TRP) channels constitute
a large family of ion channels activated by various chemicals and temperature changes, and are
involved in various physiological functions [18–20]. TRP channels are present in the pharynx, larynx,
and NPJc [20–22]. Immunohistochemistry showed localization of transient receptor potential vanilloid
1 (TRPV1) and vanilloid 2 (TRPV2) in the pharynx [22]. Transient receptor potential melastatin
8 (TRPM8)-immunoreactive (IR) nerve fibers are present in the posterior portion of the soft palate and
in the border region of the naso–oral and laryngeal parts of the pharynx [21]. TRPM8-IR was also
observed on the mucosa of the larynx and on the laryngeal side of the epiglottis [21]. TRPV1 channels
are also present in the human oropharynx and larynx [23,24]. The presence of TRP channels in
these regions raises the possibility of their involvement in the responses of the sensory nerves to
various chemicals.
The SLN, which supplies the larynx and associated laryngopharyngeal regions, plays an important
role in the swallowing reflex [1,2,4,5,8]. Mechanical or electrical stimulation of SLN-innervated regions
readily evokes the swallowing reflex [4–6,25]. The mucosa of these regions is much more highly
innervated than the skin or the mucosa of the oral cavity [26]. The mucosa of these regions is
richly innervated by free nerve endings [27,28] and many of the sensory nerve fibers of the SLN are
unmyelinated [29]. It is highly likely that these unmyelinated nerve fibers are involved in evoking
the swallowing reflex. The swallowing reflex is a vital reflex that not only allows the passage of
food and drink into the stomach but also prevents their entry into the lungs [30,31]. Dysfunction of
the swallowing reflex (oropharyngeal dysphagia) is a major health problem among elderly people
and people with neurological disorders (e.g. Parkinson’s and Alzheimer’s diseases, and following
a stroke) [32,33]. Therefore, potential strategies that can facilitate the swallowing reflex are important.
Previous studies observed that the application of capsaicin incorporated in a solution, troche,
or food [34–36] or adding of natural capsaicinoids in alimentary bolus [37,38] reduced the delay
of the swallowing reflex and improved the safety and efficacy of swallowing in human patients
with dysphagia. Infusion of a menthol solution in the pharynx (10 mM menthol showed best
response) [39] and adding of menthol in alimentary bolus [38] also reduced the delay of the swallowing
reflex [39] and the laryngeal vestibule closure time (an indicator of swallowing safety) [38] in human
patients with dysphagia. The findings of these studies suggest that TRPV1 and TRPM8 agonists can
improve swallowing function. However, as those studies were conducted in human subjects, specific
involvement of TRPV1 and TRPM8 channels could not be tested by using pharmacological antagonists
of the respective channels. In addition, evaluating the nerve activity that supply the pharynx and
laryngeal regions following application of agonists and antagonists, and the amount or pattern of
expression of TRPV1 and TRPM8 channels in the NPJc was not possible. Animal model use in the
present study allows us to understand the underlying mechanism of capsaicin and menthol evoked
improvement of the swallowing function observed in human studies. It also allows us to focus on
a particular nerve (SLN) that innervates the larynx and associated laryngopharyngeal regions.
In the present study, we explored whether TRPV1 and TRPM8 are present in the afferent
nerves innervating the larynx and associated laryngopharyngeal regions, whether activation of these
channels can modulate SLN activity, and whether activation of these channels has any effect on the
swallowing reflex.
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2. Results
2.1. TRPV1 and TRPM8 Expression in the NPJc
TRPV1 and TRPM8 immunoreactivity was observed in the cell bodies present in the nodose,
petrosal, and jugular ganglia (Figures 1 and 2). Around 23−52% of fluoro gold-stained neurons
expressed TRPV1 (Figure 1C) and around 46−50% of fluoro gold-stained neurons expressed TRPM8
(Figure 2C). Neurons expressing TRPV1 or TRPM8 that did not express NF-200 were more than twice
as numerous as neurons that expressed TRPV1 or TRPM8 and NF-200 (Figures 1C and 2C).
Figure 1. (A) Photomicrographs of TRPV1 localization in the NPJc. Black-filled arrows indicate
examples of cells positive for FG, TRPV1 and NF-200. White arrowheads indicate examples of cells
positive for both FG and TRPV1, but negative for NF-200. (B) Number of TRPV1-positive cells in nodose
(NG), petrosal (PG), and jugular (JG) ganglia. (C) Percentage of TRPV1-positive cells in nodose (NG),
petrosal (PG), and jugular (JG) ganglia. FG(+): Cells stained with FG. FG(+)/TRPV1(+): FG-stained
cells immune-positive for TRPV1. FG(+)/TRPV1(−): FG-stained cells immune-negative for TRPV1.
FG(+)/NF(+): FG-stained cells immune-positive for NF-200. FG(+)/TRPV1(+)/NF(+): FG-stained cells
immune-positive for TRPV1 and NF-200. FG(+)/TRPV1(+)/NF(−): FG-stained cells immune-positive
for TRPV1 but not NF-200. NPJc: nodose-petrosal-jugular ganglionic complex. FG: fluoro-gold. NF-200:
neurofilament-200. IR: immunoreactive. Scale bars represent 100 µm.
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Figure 2. (A) Photomicrographs of TRPM8 localization in the NPJc. Black-filled arrows indicate
examples of cells positive for FG, TRPM8, and NF-200. White arrowheads indicate examples of cells
positive for both FG and TRPM8, but negative for NF-200. (B) Number of TRPM8-positive cells
in nodose (NG), petrosal (PG), and jugular (JG) ganglia. (C) Percentage of TRPM8-positive cells in
nodose (NG), petrosal (PG), and jugular (JG) ganglia. FG(+): Cells stained with FG. FG(+)/TRPM8(+):
FG-stained cells immuno-positive for TRPM8. FG(+)/TRPM8 (−): FG-stained cells immuno-negative
for TRPM8. FG(+)/NF(+): FG-stained cells immuno-positive for NF-200. FG(+)/TRPM8(+)/NF(+):
FG-stained cells immuno-positive for TRPM8 and NF-200. FG(+)/TRPM8(+)/NF(−): FG-stained cells
immuno-positive for TRPM8 but not NF-200. NPJc: nodose-petrosal-jugular ganglionic complex. FG:
fluoro-gold. NF-200: neurofilament-200. IR: immunoreactive. Scale bars represent 100 µm.
2.2. SLN Response to Stimulating Solutions
The SLN showed spontaneous activity during resting conditions (baseline activity). There was
an initial increase of SLN activity upon delivery of the stimulating solutions (Figures 3A and 4A).
Following the initial response, the increased SLN activity gradually returned towards baseline levels
for all stimulating solutions except for distilled water. For distilled water, the increased SLN activity
persisted for a long time and did not returned to the baseline level (Figures 3 and 4). When SLN
activities evoked by different concentrations of capsaicin were compared, the highest activity was
observed for 25 µM capsaicin (Figure 3A,B). The SLN activity for 25 µM capsaicin was significantly
more (P < 0.05) than that for 12.5 µM and 100 µM capsaicin until 10 s after delivery of the solution
(Figure 3B). The activity was also significantly higher (P < 0.05) than that produced by saline or
vehicle (Figure 3C) until 18 s after delivery of the solution. The SLN activity for 100 µM capsaicin
was similar to that for 12.5 µM capsaicin (Figure 3B). When SLN activity was compared among the
different concentrations of menthol, 50 mM menthol showed the highest SLN activity (Figure 4A,B).
The SLN activity for 50 mM menthol was significantly higher (P < 0.05) compared with that produced
by 12.5 mM or 25 mM menthol until 10 s after delivery of the stimulating solution (Figure 4B). The SLN
activity for 50 mM menthol was also significantly higher (P < 0.05) than that for saline or vehicle
(Figure 4C) until 12 s after delivery of the solution. For 100 mM menthol, the SLN activity declined
following the initial response and the activity decreased below the baseline level (Figure 4A,B).
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Figure 3. (A) The response of the superior laryngeal nerve (SLN) to capsaicin and other stimulating
solutions. Arrowheads indicate onset of delivery of the stimulating solutions. (B) SLN responses to
different concentrations of capsaicin. (C) Comparison of SLN responses to capsaicin, saline, vehicle,
and distilled water. The y-axis shows the area of the integrated SLN response calculated for every 2 s
from the onset of infusion of stimulating solutions. Arb. Unit: arbitrary unit. S: seconds.
Figure 4. (A) The response of the superior laryngeal nerve (SLN) to menthol and other stimulating
solutions. Arrowheads indicate onset of delivery of the stimulating solutions. (B) SLN responses to
different concentrations of menthol. (C) Comparison of SLN responses to menthol, saline, vehicle,
and distilled water. The y-axis shows the area of the integrated SLN response calculated for every 2 s
from the onset of infusion of stimulating solutions. Arb. Unit: arbitrary unit. S: seconds.
2.3. Effect of TRPV1 and TRPM8 Antagonists on the SLN Response
We investigated the effect of topical application of TRPV1 and TRPM8 antagonists (AMG 9810
and AMTB as TRPV1 and TRPM8 antagonists, respectively) on the SLN response to 25 µM capsaicin
and 50 mM menthol, respectively. These concentrations of capsaicin and menthol were chosen because
they produced the highest SLN activity (Figures 3B and 4B). Capsaicin or menthol was delivered
10 minutes after application of the TRPV1 or TRPM8 antagonists. As shown in Figure 5A, prior topical
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application of the TRPV1 antagonist significantly attenuated (P < 0.05) capsaicin-evoked SLN activity.
Menthol-evoked SLN activity was also significantly attenuated (P < 0.05) by prior topical application
of the TRPM8 antagonist (Figure 5B).
Figure 5. Effect of prior application of TRPV1 and TRPM8 antagonists (AMG 9810 and AMTB as TRPV1
and TRPM8 antagonists, respectively) on respective agonist-evoked superior laryngeal nerve (SLN)
responses. (A) SLN response following application of TRPV1 antagonist. (B) SLN response following
application of TRPM8 antagonist. The y-axis shows the area of the integrated SLN response calculated
for every 2 s from the onset of infusion of stimulating solutions. Arb. Unit: arbitrary unit. S: seconds.
2.4. Swallowing Reflex Evoked by Stimulating Solutions and Effect of TRPV1 and TRPM8 Antagonists on
the Reflex
To understand whether activation of TRPV1 and TRPM8 have any effect on the swallowing reflex,
we investigated the swallowing reflex evoked by local delivery of the stimulating solutions to the
larynx and associated laryngeal regions. Along with distilled water, saline, and vehicle, we used 25 µM
capsaicin and 50 mM menthol as stimulating solutions. Delivery of saline or vehicle (saline with small
amount of ethanol) evoked 0 to 3 swallowing reflexes (Figures 6 and 7).
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Figure 6. (A) Swallowing reflexes evoked by application of capsaicin and other stimulating solutions.
Arrowheads indicate onset of delivery of the stimulating solutions. (B) Swallowing reflexes evoked by
capsaicin following application of TRPV1 antagonist. (C) Comparison of the number of swallowing
reflexes evoked by distilled water and capsaicin. (D) Comparison of the interval between swallowing
reflexes evoked by distilled water and capsaicin. Cap: capsaicin.
Figure 7. (A) Swallowing reflexes evoked by application of menthol and other stimulating solutions.
Arrowheads indicate onset of delivery of the stimulating solutions. (B) Swallowing reflexes evoked by
menthol following application of TRPM8 antagonist. (C) Comparison of the number of swallowing
reflexes evoked by distilled water and menthol. (D) Comparison of the interval between swallowing
reflexes evoked by distilled water and menthol. Men: Menthol.
Capsaicin evoked a considerable number of swallowing reflexes and the number of evoked
reflexes (15.67± 1.17 and 3.17± 0.87, before and after TRPV1 antagonist, respectively) was significantly
reduced (P < 0.001) by prior local application of the TRPV1 antagonist (Figure 6A–C). Application of
vehicle for the TRPV1 antagonist did not reduce the number of capsaicin-evoked swallowing reflexes
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(17.50 ± 0.92) (Figure 6C). The number of swallowing reflexes evoked by capsaicin was significantly
more (P < 0.001) than that evoked by distilled water (6.67 ± 0.67) (Figure 6C). The interval between
the evoked swallowing reflexes was significantly shorter (P = 0.002) for capsaicin (0.73 ± 0.03 s)
compared with that for distilled water (1.39 ± 0.15 s) (Figure 6D). Menthol-evoked swallowing reflexes
(13.17 ± 1.60) were also significantly more (P = 0.014) numerous than those evoked by distilled water
(7.67 ± 0.92) and prior topical application of TRPM8 antagonist significantly attenuated (P < 0.001) the
menthol-evoked swallowing reflexes (3.50 ± 1.12) (Figure 7A–C). The interval between the evoked
swallowing reflexes was significantly shorter (P = 0.002) for menthol (0.90 ± 0.06 s) compared with
that for distilled water (1.33 ± 0.08 s) (Figure 7D).
2.5. Effect of SLN Transection on the Evoked Swallowing Reflex
To confirm that the swallowing reflexes evoked by the delivery of stimulating solutions to the
larynx and associated laryngopharyngeal region were controlled by the SLN under the experimental
setup of this study, we investigated the effect of SLN transection on the number of evoked swallowing
reflexes. Unilateral SLN transection significantly reduced (P = 0.009, before vs. after unilateral SLN
transection for water; P < 0.001, before vs. after unilateral SLN transection for capsaicin and menthol)
the number of evoked swallowing reflexes, while bilateral SLN transection prevented the swallowing
reflex altogether (Figure 8A–D).
Figure 8. Swallowing reflexes evoked by application of distilled water, capsaicin, and menthol before
SLN transection (A), following unilateral (B) and following bilateral SLN transection (C). Arrowheads
indicate onset of delivery of the stimulating solutions. (D) Comparison of the number of swallowing
reflexes before and after unilateral SLN transection evoked by distilled water, menthol, and capsaicin.
Men: Menthol, Cap: Capsaicin, Uni. SLN T.: Unilateral transection of the superior laryngeal nerve.
3. Discussion
In the present study, we investigated the expression pattern of TRPV1 and TRPM8 in the NPJc,
the SLN activity following activation of these channels, and the role of these channels in mediating
sensory information through the SLN and their contribution to the swallowing reflex. TRPV1 and
TRPM8 were expressed in the NPJc, where the cell bodies of afferent neurons from the SLN are located.
The majority of neurons in the NPJc that express TRPV1 and TRPM8 were unmyelinated neurons
and a minority were myelinated. Topical application of TRPV1 and TRPM8 agonists (capsaicin and
menthol, respectively) to the larynx and associated laryngopharyngeal regions modulated SLN activity
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and evoked the swallowing reflex. The number of swallowing reflexes evoked by TRPV1 or TRPM8
agonists was greater than the number of water-evoked swallowing reflexes. The SLN activity and
the swallowing reflexes evoked by capsaicin and menthol were attenuated by TRPV1 and TRPM8
antagonists, respectively.
We focused on the SLN, therefore, we transected the other nerves (IX-ph, X-ph and RLN) known
to be involved in the swallowing reflex [4,6–8]. We created a window in the trachea just below the
cricoid cartilage to deliver solutions to the SLN-innervated regions.
Electrical stimulation of the SLN readily elicits the swallowing reflex, indicating an important
role of this nerve in the swallowing reflex [5,25,40,41]. The SLN mainly innervates the larynx and
associated laryngopharyngeal regions [8–12] and responds to water and various chemicals applied
to those regions [13–17]. The molecular basis of this response is not fully understood. Recently, TRP
channels were detected in the larynx, its associated regions [20–24], and the NPJc [20], raising the
possibility that these channels are involved in the transduction of chemical stimuli. In the present study,
we observed that topical application of capsaicin (a TRPV1 activator) and menthol (a TRPM8 activator)
to the larynx and associated laryngopharyngeal regions modulated SLN activity. Capsaicin at a dose
of 25 µM and menthol at a dose of 50 mM produced higher SLN responses compared with responses
to saline or vehicle. The SLN responses to capsaicin and menthol were suppressed by prior topical
application of TRPV1 and TRPM8 antagonists, respectively, indicating involvement of these channels
in the responses. A high concentration of menthol (100 mM) caused a brief increase in SLN activity
followed by a reduction to below the baseline level. The underlying mechanism of this decrease in
SLN activity may result from desensitization of TRPM8 channels and inhibition of other ion channels
by the high menthol concentration. In vitro studies show that menthol can interact with other ion
channels, including voltage-gated sodium channels [42,43]. A biphasic effect of menthol on neuronal
discharge was observed in previous in vivo studies, in which spinal dorsal horn neuronal discharge in
response to skin cooling was augmented by application of a low concentration of menthol, while a high
concentration of menthol decreased the neuronal discharge and increased the threshold of cold stimuli
on the skin [44,45]. Desensitization of TRPM8 by high menthol concentrations may occur via depletion
of phosphatidylinositol 4,5-bisphosphate (PIP2) after phospholipase C (PLC) activation [46–48] or
calcium-mediated activation of calmodulin [49]. In the case of capsaicin, a high concentration
(100 µM) did not increase SLN activity but evoked a similar level of activity to that produced by
a low concentration of capsaicin. This phenomenon may also be attributed to desensitization of
TRPV1 by the high capsaicin concentration [50–52]. It has been reported that application of a high
concentration or long duration of capsaicin causes high Ca2+ influx into the cell and desensitizes the
TRPV1 to protect the cell from toxic Ca2+ overload. Similar to TRPM8, desensitization may occur
by activation of the calcium-binding protein calmodulin that binds with TRPV1 to desensitize it.
Depletion of PIP2 and alteration of the dynamic balance between the Ca2+-dependent phosphorylation
and dephosphorylation of the receptor protein may also contribute to the desensitization [50–52].
To understand whether activation of TRPV1 or TRPM8 channels can evoke the swallowing
reflex, we stimulated the SLN-innervating regions with 25 µM capsaicin or 50 mM menthol.
These two concentrations were chosen because they produced the highest SLN activity
(Figures 3B and 4B). Capsaicin and menthol evoked many swallowing reflexes while saline or vehicle
evoked no or few swallowing reflexes. Distilled water was previously observed to be an effective
stimulus to evoke the swallowing reflex [4,13,25,53,54]. In the present study, we diluted capsaicin
and menthol with saline (not with distilled water) to prevent any influence of distilled water on
the SLN afferents. We observed that the capsaicin and menthol-evoked swallowing reflexes were
greater in number than the water-evoked reflexes, indicating TRPV1 and TRPM8 agonists can be
good stimuli to evoke the swallowing reflex. In addition, the number of capsaicin or menthol-evoked
swallowing reflexes was significantly reduced following topical application of TRPV1 or TRPM8
antagonists, indicating that these channels are involved. TRPV1 and TRPM8 immunoreactivities in the
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afferent nerves and epithelial cells of the larynx and associated laryngopharyngeal regions have been
reported [20–23].
In our study, we observed that TRPV1 and TRPM8 are expressed in a considerable percentage
of afferent neurons from the SLN-innervating regions. They were largely (around two-thirds)
expressed in non-NF200-IR neurons, indicating their presence majorly in unmyelinated neurons
(C-neurons). Around one-third of TRPV1 and TRPM8 expressing neurons were myelinated neurons.
Previous studies also show that generally, TRPV1 and TRPM8 are mainly expressed in unmyelinated
neurons and partly in thinly myelinated neurons (Aδ-neurons) [55–60]. These observations indicate
that facilitation of the swallowing reflex by capsaicin and menthol observed in the present study mostly
involved unmyelinated neurons (C-neurons) and partly myelinated neurons (probably Aδ-neurons).
The influence of unmyelinated neurons or thinly myelinated neurons (Aδ-neurons) in pharyngeal and
laryngeal regions in evoking the swallowing reflex has not been extensively studied. This may be
because the swallowing reflex is readily evoked by light mechanical stimulation of the pharyngeal
and laryngeal mucosa and by low intensity electrical stimulation of the SLN (mostly activation
of Aβ-neurons) [5,6]. In a previous study in human subjects, we observed that low intensity
(non-noticeable) electrical stimulation of the pharyngeal regions readily evoked the swallowing
reflex and that swallowing reflex latency became shorter as the stimulus frequency increased [3].
These findings indicate that the activation of Aβ-neurons can evoke the swallowing reflex. However,
afferent neurons innervating the pharyngeal and laryngeal regions contain a large percentage of
unmyelinated neurons (C-neurons) [27–29,61]. Facilitation of the swallowing reflex by unmyelinated
neurons is of particular interest because utilization of these neurons may be a good strategy for
facilitating the swallowing reflex in patients with oropharyngeal dysphagia. Recent studies in patients
with oropharyngeal dysphagia reported that addition of a natural capsaicinoid (a TRPV1 agonist,
150 µM) to the alimentary bolus improved the efficacy of swallowing and reduced the prevalence
of pharyngeal residues and penetrations of bolus particles into the larynx [37]. It also shortened the
laryngeal vestibule closure time and enhanced hyoid motion in oropharyngeal dysphagia patients [37].
In another study in oropharyngeal dysphagia patients, a TRPV1 agonist (capsaicinoid, 150 µM) had
a better therapeutic effect on improving swallowing compared with a TRPM8 agonist (menthol,
1 mM or 10 mM) [38]. This study also showed that addition of TRP agonists (capsaicinoid as TRPV1
agonist, 150 µM/menthol as TRPM8 agonist, 1 mM or 10 mM/piperine as TRPA1 and TRPV1 agonists,
150 µM or 1 mM) to the bolus decreased the bolus passing time through the pharynx and reduced
the swallowing response time and laryngeal penetrations in dysphagia patients [38]. In addition,
in aged people with dysphagia, a TRPV1 or TRPM8 agonist (capsaicin or menthol) applied to the
pharynx significantly shortened the latency of the evoked swallowing reflex compared with that
for distilled water [39,62]. These studies in humans, along with the findings of the present study,
strongly indicate that targeting TRP channels can be a potential new therapeutic avenue to treat
oropharyngeal dysphagia.
In the NG, the number of TRPM8-immunoreactive SLN-afferent neurons was significantly
higher compared with the number of TRPV1-immunoreactive SLN-afferent neurons (Figures 1 and 2).
In the PG and JG, the numbers of TRPV1- and TRPM8-immunoreactive neurons were similar.
This observation suggests that NG may contain more TRPM8-immunoreactive neurons that contribute
to menthol evoked swallowing reflexes.
In this study we have separately searched the expression of TRPV1- and TRPM8-immunoreactive
neurons in the NPJc. There is a possibility of co-expression of these two channels in the same
neurons. It will be interesting to investigate whether these two channels are co-expressed on the
same neurons or on different populations of neurons in the NPJc. This information may help to better
pharmacological targeting of the channels based on the expression pattern. Future studies should
advance our understanding in this context.
We confirmed involvement of the SLN in the evoked swallowing reflex by transection of the
SLN. Unilateral transection of the SLN significantly reduced the evoked reflexes while bilateral
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transection abolished all reflexes, indicating involvement of SLN afferents in the evoked swallowing
reflex observed under these experimental conditions. There was an approximately three-fold reduction
in the number of swallowing reflexes following unilateral SLN transection, indicating the importance of
bilateral SLNs for evoking the swallowing reflex. This observation is supported by our previous study,
where bilateral electrical stimulation of the SLN reduced the onset latency and interval time between
successive reflexes compared with responses following unilateral electrical stimulation of the SLN [40].
The spatial summation of bilateral afferent inputs may be crucial for evoking the swallowing reflex.
Absence of a swallowing reflex following bilateral transection of the SLN confirmed the involvement of
SLN afferents in evoking the swallowing reflex under the experimental conditions used in this study.
In the present study, the concentration of the TRPV1 agonist (capsaicin) was 1000 times lower than
that of the TRPM8 agonist, and this low TRPV1 agonist dose evoked a larger number of swallowing
reflexes, indicating that the TRPV1 agonist may be a better stimulus for evoking the swallowing reflex
compared with the TRPM8 agonist. This observation concurs with a study conducted in human
patients with dysphagia [38]. The large number of swallowing reflexes evoked by a low dose of
TRPV1 agonist may be attributed to a central mechanism working in the swallowing central pattern
generator (sCPG). TRPV1 is densely localized in the terminal ends of solitary tract afferents located
in the nucleus tractus solitarii (NTS) [60,63] and activation of these afferents causes release of the
excitatory neurotransmitter, glutamate, which generates excitatory postsynaptic currents (EPSCs)
in the postsynaptic neurons [64–69]. In vitro activation of TRPV1-positive solitary tract afferents
caused synchronous and long lasting asynchronous release of glutamate in the NTS, while activation
of TRPV1-negative afferents caused only synchronous release of glutamate [65–67]. In addition,
increasing the number of activated TRPV1-positive solitary tract afferents increased the asynchronous
release of glutamate [64,66]. Glutamate is an important excitatory neurotransmitter in generating
the swallowing reflex [4,5,70]. Considering the above findings, it may be possible that activation of
TRPV1-containing afferent fibers by capsaicin caused long lasting release of glutamate in the sCPG,
which contributed to enhancement of the swallowing reflex.
We observed that topical application of distilled water in the larynx and associated
laryngopharyngeal regions initiated long lasting SLN activity and the activity was significantly higher
than the capsaicin and menthol evoked SLN activity at the later time points following application of
the solutions (Figures 3 and 4). However, this long lasting activity did not evoke more swallowing
reflexes compared with the number of swallowing reflexes evoked by capsaicin or menthol. On the
other hand, application of capsaicin (25 µM) or menthol (50 mM) evoked high SLN activity (at early
time points following the application) but the activity was not as long lasting as observed for distilled
water, however, they produced more swallowing reflexes compared with the number for distilled
water. These observations suggest that the evoking of swallowing reflexes was not parallel with the
SLN activity. The exact mechanism of this phenomenon is not clear; however, some possibilities can be
speculated. The early SLN firing may be more influential to activate the sCPG located in the brainstem
for evoking swallowing reflexes. In addition, chemical activation of unmyelinated afferent neurons
may release a large amount of excitatory neurotransmitters in the sCPG, responsible for repeated
evoking of swallowing reflexes. In this context, in vitro activation of TRPV1-positive solitary tract
afferents was observed to cause long lasting asynchronous release of glutamate in the NTS [64–66],
where the pattern generator for the swallowing reflex is located [4,25]. However, these hypotheses
require evaluation in future studies.
4. Materials and Methods
4.1. Ethical Approval
The protocol of this study was approved by the Animal Care Committee of Matsumoto Dental
University (Ref. No. 277, 14 April 2017) and all experiments were carried out in accordance with
the guidelines of the committee and the National Institute of Health Guide for the Care and Use of
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Laboratory Animals. Every effort was made to minimize animal suffering and to reduce the number
of animals used.
4.2. Animals
All experiments involved male Sprague-Dawley rats weighing 200–300 g. Animals were housed
under standard conditions at 22 ± 2 ◦C, 40 ± 5% relative humidity, and a photoperiod of 12 h light:
12 h dark. Food and water were provided ad libitum.
4.3. Surgical Preparation
Rats were anaesthetized with urethane (1.0–1.5 g/kg, administered intraperitoneally) and were
fixed in the supine position with adhesive tape. The adequacy of the anaesthesia was checked
by noxious pinching of the hind paw to determine if a withdrawal reflex was evoked, and if so,
a supplementary dose of urethane was given. A midline incision was made in the ventral surface of
the neck. The trachea was isolated from surrounding tissues and a cannula was inserted towards the
lungs to maintain respiration. A small area of trachea (ventral portion only) was surgically removed
just below the cricoid cartilage to make a window for delivering solutions. This window reduced
the pressure produced in the larynx and associated laryngopharyngeal regions during delivery of
stimulating solutions.
4.4. Transection of IX-ph, X-ph, and Recurrent Laryngeal Nerves
Along with the SLN, the pharyngeal branch of glossopharyngeal (IX-ph) and vagus (X-ph) nerves,
lingual branches of glossopharyngeal (IX-li), and the recurrent laryngeal nerves (RLN) of the vagus
nerve are also involved in the swallowing reflex [4,6–8]. In this study, we focused on the SLN;
therefore, pharyngeal branches of glossopharyngeal (IX-ph) and vagus (X-ph) nerves, lingual branches
of glossopharyngeal (IX-li) nerves, and recurrent laryngeal nerves (RLN) of the vagus nerve were
transected bilaterally prior to recording from the SLN. The IX-ph, IX-li, and X-ph branches were
exposed by retraction of the digastric muscle and the horn of the hyoid bone. The recurrent laryngeal
nerves (RLN) were exposed from either side of the trachea. Transection of these nerves was performed
before exposing the SLN.
4.5. Exposing the SLN and Recording of SLN Activity
The sternothyroid muscle was blunt dissected and the SLN was freed from the surrounding tissues.
Bilateral SLN were transected near the end, where the SLN joins with the vagus nerve. Bipolar silver
wire electrodes (0.1 mm diameter) were then placed on the SLN unilaterally. Liquid silicone was poured
over the electrodes to fix the electrode with the nerve. The silicone spread around the electrodes to
isolate them from the surrounding tissues. The silicone also prevented the nerve from drying, allowing
the nerve to be recorded for a long time [5]. The SLN activity was amplified and integrated with a time
constant of 0.3 s. The data were digitized by the Cambridge Electronics Power 1401 data acquisition
system (Cambridge Electronic Design Ltd., Cambridge, UK) and stored for later analysis.
4.6. Recording of Swallowing Reflexes
Before recording the swallowing reflex, bilateral SLNs were kept intact and bilateral RLN, IX-ph,
X-ph, and IX-li nerves were transected. The swallowing reflex was identified by electromyogram (EMG)
activity of the mylohyoid muscle and by characteristic visual observation of laryngeal movement.
To record EMG activity during swallowing, bipolar urethane-coated stainless steel fine wire electrodes
(Unique Medical Co., Ltd., Tokyo, Japan) were implanted into the mylohyoid muscle and EMG
signals were amplified and digitized by the Cambridge Electronics Power 1401 data acquisition system
(Cambridge Electronic Design Ltd., Cambridge, UK) and stored for later analysis.
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4.7. Stimulating Solutions and Delivery of the Solutions
The stimulating solutions were distilled water (DW), normal saline (0.9% NaCl), menthol
(12.5 mM, 25 mM, 50 mM, and 100 mM), capsaicin (12.5 µM, 25 µM, 50 µM, and 100 µM), and vehicle
(vehicle for highest concentration of menthol or capsaicin). Menthol and capsaicin (Wako Pure
Chemical Industries Ltd. Osaka, Japan) were dissolved in small amounts of 100% ethanol and diluted
in normal saline to achieve the desired concentration. The concentration of capsaicin and menthol
was determined from a pilot study where we started with different concentrations of capsaicin and
menthol and searched for the concentrations that can change the SLN activity. Stimulating solutions
were topically delivered using a syringe with a 21 gauge needle with a blunted tip. During delivery
of the stimulating solution, the blunted needle tip was placed into the window (created just below
the cricoid cartilage) and directed towards the larynx. Fifty microliters of a stimulating solution was
delivered in one second. The SLN responses and swallowing reflexes were recorded for 20 seconds
after the delivery of the stimulating solutions. The interval between the deliveries of the stimulating
solutions was 5 minutes. During this interval time, the delivered solution was aspirated out and saline
was delivered and aspirated out several times to wash the region. Pointed pieces of tissue paper were
inserted through the window to absorb the remaining saline. All stimulating solutions were applied at
room temperature (24–25 ◦C).
4.8. TRPM8 and TRPV1 Antagonists
AMG 9810 (2E)-N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl)phenyl]-2-
propenamide (Enzo Life Sciences, Inc. NY, USA) and AMTB [N-(3-aminopropyl)-2-{[(3-methylphenyl)
methyl]oxy}-N-(2-thienylmethyl)benzamide hydrochloride salt] (Wako Pure Chemical Industries
Ltd. Osaka, Japan) were used as TRPV1 and TRPM8 antagonists, respectively. Various in vitro
and in vivo studies showed the effeicacy of AMG 9810 and AMTB to block TRPV1 and TRPM8,
respectively [71–76]. AMG 9810 was dissolved in small amount of DMSO and Tween 80 and diluted
in normal saline. Solution containing DMSO, Tween 80, and normal saline was used as vehicle
for AMG 9810. AMTB was dissolved in normal saline. Different concentrations of AMG 9810 and
AMTB were used to determine the lowest effective concentrations at which they could inhibit and
attenuate the nerve response or the number of swallowing reflexes evoked by menthol or capsaicin.
The concentration that attenuated the agonist-evoked nerve response or the number of swallowing
reflexes to half or less than half, was used as an effective lowest concentration. The effective lowest
concentration for AMG 9810 was 125–250 µM. The effective lowest concentration for AMTB was
62.5 µM.
4.9. Immunohistochemistry
Fluoro-gold (FG, 4%) was injected bilaterally into the larynx and associated laryngopharyngeal
regions and into the SLN under sodium pentobarbital anaesthesia (50 mg/kg, administered
intraperitoneally). Before injection of FG, bilateral RLN, IX-ph, X-ph, and IX-li nerves but not
the SLN were transected to allow the passage of FG only through the SLN. Three days later, rats
were deeply anesthetized and perfused with saline followed by 4% paraformaldehyde. The NPJcs
were removed and immersed in the same fixative. The NPJcs were sectioned at a thickness of
16 µm using a cryostat. Sections were incubated with rabbit polyclonal anti-TRPM8 and anti-TRPV1
antibodies (1:5000 for anti-TRPM8 (Cat# ACC-049) and 1:1000 for anti-TRPV1 (Cat #: ACC-030),
Alomone, Israel) and a mouse monoclonal anti-neurofilament-200 antibody (1:1000, Cat# N0142,
Sigma-Aldrich, USA) overnight, and processed with appropriate secondary antibodies (labelled with
Alexa Fluor 594 and 488 (Molecular Probes, USA)). The sections were cover slipped using ProLong
Diamond Anti-fade Reagent (Life technologies, USA) and were examined using a BZ-X700 fluorescence
microscope (Keyence Corp., Japan). No immunoreactivity of TRPV1 and TRPM8 was observed when
primary antibodies for TRPV1 and TRPM8 were omitted during immunohistochemical procedure
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(Figures 1A and 2A). The same anti-TRPM8, anti-TRPV1, and anti-NF-200 antibodies were used in
previous published studies to detect TRPV1-, TRPM8-, and NF-200-immunoreactive neurons in the
other ganglia (e.g., in trigeminal ganglia and dorsal root ganglia) in rats [57,77]. Immunoreactive cells
were counted from a region of interest using ImageJ software (NIH Image, USA) in a horizontal section
where the highest number of TRPV1-IR or TRPM8-IR cells was observed. Three sections from each
rat (one with the largest number of labelled cells and the following two serial sections) were used
for counting.
4.10. Data Analysis
SLN responses were analysed as the area of the integrated response above the baseline, using
Spike2 software (Cambridge Electronic Design Ltd., Cambridge, UK). The area of the integrated
SLN response was calculated for every 2 s from the onset of infusion of stimulating solutions for 20 s
following the stimulation. The area of stable baseline activity for 2 s (before onset of stimulating solution
infusion) was subtracted from the area of every 2 s response following the onset of the stimulation.
The number of evoked swallowing reflexes in the 20 s following the application of stimulating solutions
was counted. The swallowing reflex was identified by high amplitude electromyogram (EMG) activity
of the mylohyoid muscle and by characteristic visual observation of laryngeal movement. Each high
amplitude firing in EMG corresponds to 1 swallowing reflex. The average interval between swallowing
reflexes was also calculated from the reflexes evoked within the 10 s period following the onset
of stimulating solution infusion. The time interval between the starting of high amplitude EMG
activity for one swallowing reflex and the starting of high amplitude EMG activity for the subsequent
swallowing reflex was used as the interval between the respective swallowing reflexes. When many
swallowing reflexes were evoked with relatively very short intervals, the baseline EMG activity of
mylohyoid muscle was also increased. In that case, the time point when high amplitude firing of
EMG (related to evoked swallowing reflex) exceeded the baseline activity was used for calculating the
interval between the swallowing reflexes.
4.11. Statistical Analysis
Comparison of the nerve responses to the different stimulating solutions was carried out using
two-way repeated measures ANOVA followed by Tukey’s test. Comparison of the number of evoked
swallowing reflexes to the different stimulating solutions and the comparison of nerve responses
before and after antagonist treatment was carried out using one-way ANOVA followed by Tukey’s
test. The intervals between swallowing reflexes were compared using the t-test. Differences were
considered significant at P < 0.05. All data are presented as the mean ± S.E.M except the data for
immunohistochemistry study which are presented as mean ± SD.
5. Conclusions
We have demonstrated that TRPV1 and TRPM8 are expressed in afferent neurons from the
SLN-innervating regions. Two-third of them are unmyelinated. Local application of agonists of these
channels in the SLN-innervating regions modulate the SLN activity and facilitates the evoking of
swallowing reflex. The number of agonist evoked swallowing reflexes reduced when the respective
channel’s antagonist is applied before application of the agonist. These findings suggest that TRP
channels present in the swallowing related regions can be utilized to manage oropharyngeal dysphagia.
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